Is a Risk-Based Approach Superior for Breast Cancer Screening?
Synopsis
Key Takeaways
- Personalized Screening: Focus on individual risk assessments.
- Reduced Advanced Cases: Lower likelihood of advanced breast cancer.
- 30% Without Family History: Significant number of at-risk women lack familial links.
- Guideline Transformation: Potential to reshape clinical protocols.
- Resource Allocation: Efficiently direct resources to those at higher risk.
New Delhi, Dec 27 (NationPress) A personalized approach to breast cancer screening that evaluates patients' risk factors, instead of relying solely on annual mammograms, can significantly reduce the likelihood of encountering advanced cancer cases. This is according to a recent study conducted by the University of California, San Francisco (UCSF) involving a cohort of 46,000 women across the United States. The research advocates for a transition from an age-based screening methodology to one that begins with a thorough risk assessment, allowing for tailored screening schedules for each woman.
Laura J. Esserman, the director of the UCSF Breast Care Center, stated, "These findings are poised to reshape clinical guidelines for breast cancer screening and change the way we practice medicine." Esserman elaborated that a customized approach starts with evaluating risk, which encompasses genetic, biological, and lifestyle factors, thus informing effective prevention strategies.
Breast cancer remains the most prevalent cancer among women, with approximately 2.3 million cases and 670,000 fatalities globally. Historically, screening protocols assumed uniform risk among women, predominantly basing guidelines on age, despite evidence indicating significant variability in individual risk.
The new research, published in JAMA, juxtaposed the conventional annual mammogram against an individualized risk-based screening strategy. The findings revealed that the risk-oriented approach did not elevate the rates of higher-stage cancers.
Co-author Jeffrey A. Tice, a Professor of Medicine at UCSF, remarked, "Redirecting resources from women with lower risk to those with higher risk represents a strategically efficient and effective method for screening and preventing breast cancer." Notably, the study highlighted that 30% of women who tested positive for a genetic variant elevating their breast cancer risk lacked a family history of the disease, indicating that current clinical guidelines might overlook these individuals for genetic testing.